Jennifer G. Lyons, PhD

Harvard Medical School and Harvard Pilgrim Health Care Institute

Poster(s):

• (A-316) Risk of Diabetic Ketoacidosis Across Stages of Chronic Kidney Disease in Patients with Type 1 Diabetes in the U.S. Food and Drug Administration’s Sentinel System
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (A-200) Strengthening inferential studies in the U.S. FDA Sentinel initiative: Results from a methodological demonstration project
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET